Name: Tissara Tablets
Company: FEROZSONS LABORATORIES LIMITED
Therapeutic Segment: Cardiology
Description:
Tissara (Ticagrelor) is indicated for the
• Acute coronary syndrome or a history of myocardial infarction
• Coronary Artery disease but no prior stroke or myocardial infarction
• Acute Ischemic Stroke or Transient Ischemic Attack (TIA)

TOP